VitaNova Life Sciences (VNOV) Cash from Investing Activities (2017)
VitaNova Life Sciences' (VNOV) quarterly Cash from Investing Activities came in at -$16538.0 in Q4 2017.
VitaNova Life Sciences (VNOV) Cash from Investing Activities (2017) Analysis & Trends
VitaNova Life Sciences (VNOV) has 1 years of Cash from Investing Activities data on file, last reported at -$16538.0 in Q4 2017.
- Quarterly Cash from Investing Activities changed N/A year-over-year to -$16538.0 in Q4 2017, while the trailing twelve-month figure through Jan 2020 was -$16538.0 (changed N/A YoY) and the FY2018 annual result came in at -$33914.0, changed N/A from the prior year.
- Cash from Investing Activities was little changed at -$16538.0 in Q4 2017.
- In the past five years, Cash from Investing Activities ranged from a high of -$16538.0 in Q4 2017 to a low of -$16538.0 in Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 102.57 Bn | 97.41 Bn | 3.69 Bn | -214.00 Mn |
| 2 | Cencora | 61.35 Bn | 58.53 Bn | 3.61 Bn | -240.15 Mn |
| 3 | Cardinal Health | 54.15 Bn | 49.30 Bn | 2.56 Bn | -281.00 Mn |
| 4 | Henry Schein | 10.05 Bn | 9.89 Bn | 1.10 Bn | -65.00 Mn |
| 5 | Akso Health | 671.90 Mn | 671.70 Mn | - | - |
| 6 | Edap Tms | 154.62 Mn | 133.07 Mn | 7.34 Mn | -1.26 Mn |
| 7 | Accendra Health | 90.69 Mn | 83.04 Mn | 263.41 Mn | -31.25 Mn |
| 8 | 111 | 31.31 Mn | -27.44 Mn | 18.18 Mn | 4.26 Mn |
| 9 | Cosmos Health | 13.28 Mn | 10.84 Mn | 1.51 Mn | 114,605.00 |
| 10 | VitaNova Life Sciences | 11.51 Mn | 9.91 Mn | 264,662.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2017 | -16,538.00 |
| Oct 31, 2017 | -16,538.00 |